Daimen Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Daimen Pharma
Daimen Pharma Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 November 2020 (Four years and two months 14 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dheeraj Gorukanti and Suguna Raman serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24290TG2020PTC146071
-
Company No.
146071
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Nov 2020
-
Date of AGM
31 Jul 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Daimen Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dheeraj Gorukanti
|
Director | 19-Nov-2020 | Current |
|
Suguna Raman
|
Director | 19-Nov-2020 | Current |
Financial Performance of Daimen Pharma.
Enhance accessibility to Daimen Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daimen Pharma?
Unlock access to Daimen Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Graviti Pharmaceuticals Private LimitedDheeraj Gorukanti and Suguna Raman are mutual person
-
Graviti Foundation
Dheeraj Gorukanti and Suguna Raman are mutual person
-
Yashoda Healthcare Services Private LimitedDheeraj Gorukanti is a mutual person
-
Fyzks Inspection Systems Private LimitedDheeraj Gorukanti and Suguna Raman are mutual person
-
Daimen Capital Private Limited
Dheeraj Gorukanti is a mutual person
-
Vigna Human Development Private Limited
Dheeraj Gorukanti and Suguna Raman are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Daimen Pharma?
Daimen Pharma has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daimen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daimen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.